AbbVie Inc. Share-Based Compensation 2011-2026 | ABBV
Beta
What is share-based compensation?
Share-based compensation is the non-cash expense of stock options, restricted stock units, and other equity awards granted to employees.
What is AbbVie Inc.'s current share-based compensation?
AbbVie Inc. (ABBV) annual share-based compensation for 2025 was $955.0M, a 4.83% increase from 2024. AbbVie Inc. share-based compensation for the quarter ending March 31, 2026 was $444.0M.
What was AbbVie Inc.'s share-based compensation in 2024?
AbbVie Inc. annual share-based compensation for 2024 was $911.0M, a 21.95% increase from 2023.
What was AbbVie Inc.'s share-based compensation in 2023?
AbbVie Inc. annual share-based compensation for 2023 was $747.0M, a 11.33% increase from 2022.
What is AbbVie Inc.'s 5-year share-based compensation CAGR?
AbbVie Inc. share-based compensation grew at a compound annual growth rate (CAGR) of 4.87% from FY2020 to FY2025, going from $753.0M to $955.0M over 5 years.
Share-Based Compensation History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+4.9%
FY2020
$753.0M
→
FY2025
$955.0M
111213141516171819202122232425
5 years selected
Share-Based Compensation History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $955.0M | +4.8% | 10-K |
| FY2024 | $911.0M | +22.0% | 10-K |
| FY2023 | $747.0M | +11.3% | 10-K |
| FY2022 | $671.0M | -3.0% | 10-K |
| FY2021 | $692.0M | -8.1% | 10-K |
| FY2020 | $753.0M | +75.1% | 10-K |
| FY2019 | $430.0M | +2.1% | 10-K |
| FY2018 | $421.0M | +15.3% | 10-K |
| FY2017 | $365.0M | +3.4% | 10-K |
| FY2016 | $353.0M | +25.2% | 10-K |
| FY2015 | $282.0M | +17.0% | 10-K |
| FY2014 | $241.0M | +13.7% | 10-K |
| FY2013 | $212.0M | +13.4% | 10-K |
| FY2012 | $187.0M | +14.7% | 10-K |
| FY2011 | $163.0M | - | 10-K |
Company: AbbVie Inc.Ticker: ABBVSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →